CD4 lymphopenia and risk of infection in immunogerontologically healthy elderly people

The spread of methicillin-resistant Staphylococcus aureus in a rural community: will it become a common microorganism colonizing among the general population?

Surgery today·1997

Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1997

Cell cycle modulation by hematopoietic growth factors in myelodysplastic syndromes: analysis by three-color flow cytometry.

Experimental hematology·1997

(1-->3)-beta-D-glucan determination in rat organs with limulus coagulation factor G.

Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie·1997

Plasma (1-->3)-beta-D-glucan assay and immunohistochemical staining of (1-->3)-beta-D-glucan in the fungal cell walls using a novel horseshoe crab protein (T-GBP) that specifically binds to (1-->3)-beta-D-glucan.

Journal of clinical laboratory analysis·1997

[Aprotinin 2 million KIU reduces perioperative blood loss in patients undergoing primary total hip replacement].

Masui. The Japanese journal of anesthesiology·1997

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Long-term stability of human parvovirus B19 neutralizing antibody titer trends in donor-derived pooled plasma and plasma-derived immunoglobulin product lots in Japan.

Transfusion·2026

Macrophage GLUD1 is Essential for Redox Balance and Immune Homeostasis in Cardiac Injury.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

[Natural killer cells: from basic discovery toward translational insights].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Inflammatory memory in intestinal stem cells: reframing GVHD pathogenesis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

DAPK3 activates STING to enhance antiviral response via IRF3 and NF-κB pathways in teleosts.

Zoological research·2026

Icariin against neuroinflammation: emerging evidence for gut-brain axis modulation involving short-chain fatty acids, vagal signaling, and extracellular vesicles.

Chinese journal of natural medicines·2026

CD4 lymphopenia and risk of infection in immunogerontologically healthy elderly people

Related Experiment Videos

Related Concept Videos

The spread of methicillin-resistant Staphylococcus aureus in a rural community: will it become a common microorganism colonizing among the general population?

Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment.

Cell cycle modulation by hematopoietic growth factors in myelodysplastic syndromes: analysis by three-color flow cytometry.

(1-->3)-beta-D-glucan determination in rat organs with limulus coagulation factor G.

Plasma (1-->3)-beta-D-glucan assay and immunohistochemical staining of (1-->3)-beta-D-glucan in the fungal cell walls using a novel horseshoe crab protein (T-GBP) that specifically binds to (1-->3)-beta-D-glucan.

[Aprotinin 2 million KIU reduces perioperative blood loss in patients undergoing primary total hip replacement].

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Long-term stability of human parvovirus B19 neutralizing antibody titer trends in donor-derived pooled plasma and plasma-derived immunoglobulin product lots in Japan.

Macrophage GLUD1 is Essential for Redox Balance and Immune Homeostasis in Cardiac Injury.

[Natural killer cells: from basic discovery toward translational insights].

[Inflammatory memory in intestinal stem cells: reframing GVHD pathogenesis].

DAPK3 activates STING to enhance antiviral response via IRF3 and NF-κB pathways in teleosts.

Icariin against neuroinflammation: emerging evidence for gut-brain axis modulation involving short-chain fatty acids, vagal signaling, and extracellular vesicles.

CD4 lymphopenia and risk of infection in immunogerontologically healthy elderly people

Related Experiment Videos

Related Concept Videos

Related Articles